In this large prospective study, we comprehensively assessed the relation of the ARE1 (PSA −158 G/A) polymorphism (rs266882 genotype) and prostate cancer risk, survival and pre-diagnostic plasma PSA levels. Here, KLK3 is linked to prostate cancer.